^
+ Follow Novo Nordisk Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2084735
                    [Title] => Novo Nordisk Philippines launches  movement to combat obesity pandemic
                    [Summary] => Novo Nordisk introduces The Body of Truth along with the new #BeatObesityWithMe campaign.
                    [DatePublished] => 2021-03-18 12:22:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2021/03/16/novo-lead_2021-03-16_17-32-47690_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1328330
                    [Title] => Diabetes experts warn vs nighttime low blood sugar
                    [Summary] => 

Diabetes experts have warned against the menace of “nocturnal hypoglycemia” or nighttime low blood sugar, saying this could cause serious health consequences and even death.

[DatePublished] => 2014-05-29 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1804896 [AuthorName] => Sheila Crisostomo [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => http://media.philstar.com/images/the-philippine-star/business/science-and-technology/20140529/Dr.-Richard-Elwyn-Fernando-Diabetes-Philippines.jpg ) [2] => Array ( [ArticleID] => 1261558 [Title] => World Diabetes Day marked [Summary] =>

Diabetes care pioneer and innovator Novo Nordisk kicked off the annual commemoration of World Diabetes Day at Saint Pedro Poveda College last Nov. 11, together with 800 students, faculty members and healthcare professionals.

[DatePublished] => 2013-11-28 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [3] => Array ( [ArticleID] => 1259173 [Title] => Novo Nordisk donates $100K for victims of Typhoon Yolanda [Summary] =>

Danish pharmaceutical Novo Nordisk’s headquarters in Denmark, together with the Southeast Asia region (Malaysia, Singapore, Philippines and Australia), has donated a collective amount of 650,000 Danish kroner (over $100,000) to the Danish Red Cross and the Philippines Red Cross for relief and rehabilitation efforts in areas affected by Super Typhoon Yolanda (international name Haiyan).
 

[DatePublished] => 2013-11-21 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [4] => Array ( [ArticleID] => 1253710 [Title] => Novo Nordisk marks 10th year of pre-mixed insulin, pen system [Summary] =>

In 2003, diabetes care pioneer Novo Nordisk launched an accurate and easy-to-use dual-release insulin analogue and pen system designed specifically for people with diabetes starting insulin therapy.

[DatePublished] => 2013-11-07 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [5] => Array ( [ArticleID] => 929146 [Title] => Controlling blood sugar the natural way [Summary] =>

Diabetes care pioneer Novo Nordisk has developed a novel type of medicine for type 2 diabetes that controls blood sugar the natural way.

[DatePublished] => 2013-04-11 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [6] => Array ( [ArticleID] => 919989 [Title] => FDA probes new pancreas risks with diabetes drugs [Summary] =>

The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

[DatePublished] => 2013-03-15 01:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => World [SectionUrl] => world [URL] => ) [7] => Array ( [ArticleID] => 848242 [Title] => Results of insulin therapy study revealed [Summary] =>

Results of the largest observational study on the use of insulin therapy ever conducted show that 24 weeks of treatment with a Novo Nordisk insulin analogue resulted in significant improvements in blood glucose control with low incidence of major or minor hypoglycemia.

[DatePublished] => 2012-09-13 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [8] => Array ( [ArticleID] => 43229 [Title] => Diabetes kills every 10 seconds [Summary] => [DatePublished] => 2008-02-07 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [9] => Array ( [ArticleID] => 387725 [Title] => Better diabetes care could save billions per year [Summary] => If 80% of Americans with type 2 diabetes met recommended treatment goals, over $150 billion in medical costs would be saved in the next 30 years. [DatePublished] => 2007-03-04 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) ) )
Novo Nordisk
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2084735
                    [Title] => Novo Nordisk Philippines launches  movement to combat obesity pandemic
                    [Summary] => Novo Nordisk introduces The Body of Truth along with the new #BeatObesityWithMe campaign.
                    [DatePublished] => 2021-03-18 12:22:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2021/03/16/novo-lead_2021-03-16_17-32-47690_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1328330
                    [Title] => Diabetes experts warn vs nighttime low blood sugar
                    [Summary] => 

Diabetes experts have warned against the menace of “nocturnal hypoglycemia” or nighttime low blood sugar, saying this could cause serious health consequences and even death.

[DatePublished] => 2014-05-29 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1804896 [AuthorName] => Sheila Crisostomo [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => http://media.philstar.com/images/the-philippine-star/business/science-and-technology/20140529/Dr.-Richard-Elwyn-Fernando-Diabetes-Philippines.jpg ) [2] => Array ( [ArticleID] => 1261558 [Title] => World Diabetes Day marked [Summary] =>

Diabetes care pioneer and innovator Novo Nordisk kicked off the annual commemoration of World Diabetes Day at Saint Pedro Poveda College last Nov. 11, together with 800 students, faculty members and healthcare professionals.

[DatePublished] => 2013-11-28 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [3] => Array ( [ArticleID] => 1259173 [Title] => Novo Nordisk donates $100K for victims of Typhoon Yolanda [Summary] =>

Danish pharmaceutical Novo Nordisk’s headquarters in Denmark, together with the Southeast Asia region (Malaysia, Singapore, Philippines and Australia), has donated a collective amount of 650,000 Danish kroner (over $100,000) to the Danish Red Cross and the Philippines Red Cross for relief and rehabilitation efforts in areas affected by Super Typhoon Yolanda (international name Haiyan).
 

[DatePublished] => 2013-11-21 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [4] => Array ( [ArticleID] => 1253710 [Title] => Novo Nordisk marks 10th year of pre-mixed insulin, pen system [Summary] =>

In 2003, diabetes care pioneer Novo Nordisk launched an accurate and easy-to-use dual-release insulin analogue and pen system designed specifically for people with diabetes starting insulin therapy.

[DatePublished] => 2013-11-07 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [5] => Array ( [ArticleID] => 929146 [Title] => Controlling blood sugar the natural way [Summary] =>

Diabetes care pioneer Novo Nordisk has developed a novel type of medicine for type 2 diabetes that controls blood sugar the natural way.

[DatePublished] => 2013-04-11 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [6] => Array ( [ArticleID] => 919989 [Title] => FDA probes new pancreas risks with diabetes drugs [Summary] =>

The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

[DatePublished] => 2013-03-15 01:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => World [SectionUrl] => world [URL] => ) [7] => Array ( [ArticleID] => 848242 [Title] => Results of insulin therapy study revealed [Summary] =>

Results of the largest observational study on the use of insulin therapy ever conducted show that 24 weeks of treatment with a Novo Nordisk insulin analogue resulted in significant improvements in blood glucose control with low incidence of major or minor hypoglycemia.

[DatePublished] => 2012-09-13 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [8] => Array ( [ArticleID] => 43229 [Title] => Diabetes kills every 10 seconds [Summary] => [DatePublished] => 2008-02-07 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [9] => Array ( [ArticleID] => 387725 [Title] => Better diabetes care could save billions per year [Summary] => If 80% of Americans with type 2 diabetes met recommended treatment goals, over $150 billion in medical costs would be saved in the next 30 years. [DatePublished] => 2007-03-04 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with